Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Multiple drugs

Various toxicities

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug interaction
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Wang T-F, et al. The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies. Thrombosis Research 231: 128-134, Oct 2023. Available from: URL: https://dx.doi.org/10.1016/j.thromres.2023.10.004 Wang T-F, et al. The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies. Thrombosis Research 231: 128-134, Oct 2023. Available from: URL: https://​dx.​doi.​org/​10.​1016/​j.​thromres.​2023.​10.​004
Metadaten
Titel
Multiple drugs
Various toxicities
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55718-9

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Azathioprine

Case report

Gefitinib

Case report

Hydralazine

Case report

Sotalol